What the New African Health Strategy Means for the Future
Across the continent, governments are moving from emergency response to long‑term resilience. The 10‑year regional roadmap for essential medicines, unveiled in Johannesburg, is the keystone of this shift. By slashing the current 65 % import gap, African nations aim to build a self‑sustaining pharmaceutical ecosystem that can weather global supply shocks.
Local Production and Pooled Procurement: A Game‑Changer
Under the African Continental Free Trade Area (AfCFTA), more than 15 countries have already signed agreements to share manufacturing capacity. For example, Kenya’s Nairobi Pharma hub is set to supply antimalarials to neighboring East African states, cutting transport costs by up to 30 %.
According to the WHO Africa office, pooled procurement can reduce drug prices by 20–40 % while guaranteeing quality standards. Read the full WHO brief.
Financing the Transition: From Out‑of‑Pocket to Sustainable Funding
Out‑of‑pocket spending still accounts for up to 90 % of health costs in some nations. Innovative financing—such as health bonds and blended finance models—offers a way forward. Liberia’s recent health‑resource mapping, supported by the Global Fund, identified a funding gap of US$ 150 million for the 2026 fiscal year. Closing that gap will require both domestic revenue mobilization and strategic donor alignment.
Pro tip: Ministries should integrate health budgeting into national development plans to unlock multi‑sectoral financing streams.
Emerging Disease Trends: From Mpox to Seasonal Flu
While the Mpox emergency may soon be downgraded, the continent is juggling multiple threats that demand adaptable surveillance systems.
Mpox: A Blueprint for Rapid De‑escalation
Africa CDC’s criteria for declaring an “end of epidemic” include zero sustained transmission for 42 days and the ability to trace contacts across borders. Seven countries have already met these benchmarks, paving the way for a smoother transition to routine monitoring.
Regional cooperation—particularly between the DRC and Burundi—remains critical. Strengthened cross‑border labs now process specimens twice as fast as before, according to a recent CDC report.
Seasonal Influenza: The Silent Co‑driver
Influenza activity is climbing across West, Central, and Eastern Africa, with A(H3N2) as the dominant strain. The WHO estimates that vaccination can prevent up to 75 % of hospitalizations among children aged 2‑17, yet coverage in many African nations stays below 15 %.
Integrating flu vaccination into existing campaigns—such as the annual polio drive—could boost uptake without major additional costs. UNICEF’s flu‑vaccination guide offers practical steps.
Water‑borne and Zoonotic Outbreaks: Cholera, Rift Valley Fever, Diphtheria
Three parallel crises highlight the need for a “One Health” approach that links human, animal, and environmental services.
Cholera in the DRC: Learning from the Worst Outbreak in 25 Years
More than 64,000 cholera cases and 1,900 deaths have been recorded since January. Flooding, conflict, and limited WASH (Water, Sanitation, Hygiene) infrastructure fuel the spread. Mobile water‑treatment units, deployed by UNICEF, have provided safe water to 1.2 million people so far.
Did you know? Investing $1 in WASH services can avert up to $4 in healthcare costs, according to the World Bank.
Rift Valley Fever in Mauritania: Protecting Livestock and Livelihoods
With 286 human cases and 200 animal infections, the virus threatens both health and the pastoral economy. The WHO‑supported “One Health” task force is deploying mobile labs and community awareness campaigns that have reduced animal‑to‑human transmission by 35 % in pilot districts.
Diphtheria Resurgence in Somalia: Vaccination Gaps Exposed
Over 3,200 diphtheria cases—including 1,000 children—underscore the fragility of routine immunisation. A targeted campaign in Banadir aims to vaccinate 150,000 children by the end of the year, leveraging solar‑powered cold chains to reach remote clinics.
Future Outlook: Building a Resilient African Health Landscape
Key trends point toward a more integrated, locally driven health system:
- Regional Manufacturing Hubs: Expected to supply 40 % of essential medicines by 2035.
- Digital Surveillance Networks: Real‑time data sharing will cut outbreak detection times from weeks to days.
- Financing Reform: Blended finance models are projected to reduce out‑of‑pocket expenses by 25 % within the next decade.
What Can Stakeholders Do Now?
Governments, donors, and private partners should align on three pillars: local production, pooled procurement, and sustainable financing. By doing so, the continent can transition from reactive emergency responses to proactive health security.
FAQ – Quick Answers to Common Questions
- How will local drug manufacturing affect prices?
- Local production reduces import tariffs and logistics costs, typically lowering prices by 20‑40 %.
- What is “pooled procurement”?
- It’s a collaborative buying system where multiple countries aggregate demand to negotiate better terms with manufacturers.
- Why is diphtheria re‑emerging in Somalia?
- Low routine vaccination coverage—under 50 %—combined with population displacement has created immunity gaps.
- Can the “One Health” model be applied to other diseases?
- Yes, it’s especially effective for zoonoses like Rift Valley Fever and emerging threats such as COVID‑19 variants.
